December, 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Wafik S. El-Deiry: As I leave San Diego, I am very encouraged by all the scientific progress, enthusiasm of young people
Apr 15, 2024, 12:19

Wafik S. El-Deiry: As I leave San Diego, I am very encouraged by all the scientific progress, enthusiasm of young people

Wafik S. El-Deiry shared a post on LinkedIn:

”Headed back to east coast after an outstanding American Association for Cancer Research AACR24 meeting in San Diego.

At the airport, I ran into my colleague Stanley Lipkowitz, chief of the Women’s Malignancies Branch in the National Cancer Research Center at the National Cancer Institute (NCI).

As I leave San Diego, I am very encouraged by all the scientific progress, enthusiasm of young people, the determination of my colleagues of all ages to continue making a difference in the field despite many challenges.

Thankful to AACR for the opportunity to serve as a SoMe Ambassador at this year’s annual meeting. There is still so much to catch up on through the virtual meeting.”

Wafik S. El-Deiry: As I leave San Diego, I am very encouraged by all the scientific progress, enthusiasm of young people

Source: Wafik S. El-Deiry/LinkedIn

Wafik El-Deiry, MD, PhD, FACP, FRSM, an American Cancer Society Research Professor, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University. Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. This has been the most highly cited original work published in Cell. He discovered TRAIL receptor DR5 as a p53 target, and ONC201/TIC10 as a TRAIL pathway, integrated stress response inducer, and cancer therapeutic with efficacy in diffuse midline glioma and other tumors.  He was named one of America’s Top Oncologists by the Consumer Res Council of America in 2008 and 2009. He is a practicing physician-scientist specializing in colorectal cancer treatment.

About OncoDaily

OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time it became one of the leading oncology media platforms globally.

OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.

The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”